Fact CheckerSign in

NCT06149637Recruiting

Lateral Cervical Node Dissection in Differentiated Thyroid Cancer.

Comparison of Two Routes of Surgical Approach to Lateral Cervical Node Dissection in Differentiated Thyroid Cancer Patients With Lateral Metastatic Disease: Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 29 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The objective of this study is to compare shoulder and neck morbidity and the effectiveness of cervical lateral nodal dissection in patients with differentiated thyroid cancer and lateral metastases between the anterior and posterior approaches to the sternocleidomastoid muscle (SCM)

Status (registry)
Recruiting
Study type
Interventional
Enrollment
62 (estimated)
First submitted
6 Aug 2023
Start date
1 Aug 2023
Primary completion date
31 Aug 2025
Lead sponsor
Centro de Excelencia en Enfermedades de Cabeza y Cuello
NCT number
NCT06149637

What you commit to

  • Study type: Interventional
  • Planned participants: 62
  • From 1 Aug 2023 to the primary completion date, 31 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with a history of previous neck dissection
  • Previous spinal nerve injury

Other

  • Histological confirmation of medullary or anaplastic carcinoma

Who the study is looking for

  • Patients ≥ 18 years.
  • Patients with macroscopic lymph node involvement identified by physical examination, imaging or intraoperatively in lateral neck.
  • Patients with microscopic nodal involvement confirmed by FNAB (definition by the pathologist of suspected or confirmed metastatic papillary carcinoma according to the Bethesda criteria)
  • Candidates for lateral lymph node dissection due to suspected or confirmed disease metastatic lymph nodes as defined by the treating surgeon.
  • Patients requiring or not requiring thyroidectomy and/or central dissection concomitant with the dissection

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Alma Mater de Antioquia
Coordinator of this site? Confirm its status
MedellínColombiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.